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1. Introduction  
Dietary proteins represent 10 to 20% of energy consumption. The recommended daily 
minimum intake of protein and amino acids in adults is 0.8 g per kg of body weight. 
However, no upper limit has been identified. In industrialized countries, the main sources 
of protein are milk, eggs and meat. The nutritional value of protein is influenced by several 
factors, especially the amino acid (AA) composition, protein digestibility, protein digestion 
kinetics and the ability to transfer AA for protein synthesis. Diets based on either animal or 
vegetable products supply proteins of differing quality in differing quantities. Plant proteins 
are often deficient or low in some specific indispensable AAs. Soy protein is reported as a 
“complete” protein but its overall indispensable AA content is relatively low (~85% lower 
than milk) (Wilson & Wilson, 2006).  
Epidemiological data support a positive association between protein intake and bone 
health. Protein is the precursor of AAs used for bone matrix protein synthesis. Moreover, 
studies evaluating the relationship between dietary protein and bone turnover support 
the hypothesis that high protein intake may decrease bone resorption. IGF-1 is a key 
mediator of bone growth (Geusens & Boonen, 2002) and dietary protein is an important 
regulator of circulating IGF-1 levels (Bonjour et al., 2001). However, protein is also known 
to be calciuric, though the origin of the increased calcium excretion is debated. According 
to the acid ash hypothesis, the protein-induced acid load would have a deleterious effect 
on bone (Barzel & Massey, 1998). Finally, some proteins, due to their amino acid content, 
have specific effects on bone metabolism by acting directly on bone cells or through 
indirect pathways. 
Even if the effect of nutrition on bone is not as dramatic as that of pharmaceuticals, it can be 
of great help when considering bone loss. Indeed nutrition is a lower-cost, longer-term, 
higher-compliance and wider-spread approach than pharmaceutical treatment. The 
nutritional intervention can be done alone preventively or in combination with a therapy in 
more severe cases. Some nutritional components such as calcium and vitamin D are 
recognized to have a positive effect on bone. However, the effect of protein on bone health is 
much more debated. 
This chapter reviews the literature on the subject, giving an overview of the data available 
and comparing the proposed mechanisms of action. Attention is drawn to protein quality 
and to the specific effect of some soy, collagen and milk peptides on bone metabolism. 
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2. Action of protein on bone 
The mechanism underlying the debate on the effect of protein on bone is the hormonal 
anabolic effect. It is based on the increase of bone anabolic hormone IGF-1 with the 
consumption of protein. 
2.1 Bone protein metabolism and turnover 
Type I collagen is the major structural protein distributed throughout the whole body 
accounting for 25% of total body protein and for 80% of total conjunctive tissue in humans. 
The different factors involved in bone strength include not only mineral density, crystal 
characteristics, micro architecture, geometry and morphology (size and shape), but also 
protein matrix and collagen fiber quality. Cortical bone strength, whose main role is to 
protect bone integrity, is influenced not only by porosity, presence of micro damage and 
mineral composition, but also by the orientation of collagen fibers, extent and nature of 
collagen cross-linking and number and composition of cement lines (Burr, 2002; Currey, 
2001; Seeman & Delmas, 2006; Turner, 2006). Collagen is an important component of bone, 
being the main extra cellular matrix protein for calcification and playing a role in osteoblast 
differentiation (Takeuchi et al., 1996, 1997).  
Markers of bone resorption, which measure the release of peptide resulting of the 
degradation of mature modified type 1 collagen into the serum and urine, are commonly 
used to evaluate the relationship between dietary protein and bone turnover. However, to 
better understand the effect of feeding on bone collagen turnover, a better knowledge of the 
physiology of bone collagen synthesis is needed (Babraj Smith 2005). 
2.2 Hormonal anabolic effect 
Protein has an anabolic effect on bone metabolism by upregulating Insulin-like Growth 
Factor 1 (IGF-1). IGF-1 is a peptide hormone mainly produced by the liver under the action 
of the Growth Hormone. A small percentage of IGF-1 is also produced locally by different 
cell types throughout the body, including osteoblasts (Ohlsson et al., 2009). There is good 
evidence of the anabolic effect of IGF-1 on bone and muscle, especially when considering 
age-related disorders (Perrini et al., 2010). Studies measuring IGF-1 levels under different 
protein intakes consistently report that a high protein intake increases IGF-1. This fact has 
been shown over a six-month period in young exercising subjects (Ballard et al., 2005) and 
evidence also exists in older populations of both sexes (Arjmandi et al., 2005; Dawson-
Hughes et al., 2004; Hunt et al., 2009).  
There is some evidence that this hormonal response is based on the quality of the protein 
ingested. Dawson-Hughes and colleagues showed that a fivefold increase of aromatic AA 
intake (phenylalanine and histidine) for 24 days induced an increase of IGF-1 level. On the 
other hand, a fivefold increase of branched chain AA (leucine and isoleuine) induced no 
effect on IGF-1, indicating that the protein intake effect on IGF-1 is probably AA-dependent 
(Dawson-Hughes et al., 2007). Moreover, two studies comparing milk and soy protein 
reported that soy induces a greater increase of IGF-1 (Arjmandi et al., 2003; Khalil et al., 
2002). However, it is important to note that the soy protein contained isoflavone in both 
studies, thus the effect on IGF-1 could be attributed to this molecule rather than to the AA 
content.  
www.intechopen.com
 
Dietary Protein and Bone Health 
 
123 
The effect of protein intake on IGF-1 level could involve Calcium-Sensing Receptor (CaSR) 
which was also reported to be implicated in the calciuric effect of protein (Conigrave et al., 
2008). In vitro investigations showed that CaSR is expressed in hepatocytes (Canaff et al., 
2001). The activation of CaSR in the liver by AA could explain the increased IGF-1 level due 
to protein consumption. Moreover, osteoblasts also express CaSR and produce IGF-1 under 
its regulation. CaSR also upregulates numerous bone forming mechanisms and inhibits 
bone resorption (Marie, 2010). Aromatic AA supplementation induces an increase in IGF-1 
while branched chain AAs have no effect (Dawson-Hughes et al., 2007). This is consistent 
with the findings of Conigrave et al., that aromatic AAs are the most potent activators of 
CaSR, while branched chain AAs are the less potent ones (Conigrave et al., 2000).  
There is no doubt that protein induces an increase of IGF-1 level. By doing so and according 
to what is known of IGF-1, protein is likely to have an anabolic effect on bone. The proposed 
mechanism would be that a high protein intake (especially one rich in aromatic AAs) would 
activate CaSR in hepatocytes and osteoblasts and stimulate IGF-1 production, which would 
in turn exert an anabolic effect on bone. 
2.3 Bone turnover markers 
Bone turnover markers are measured in blood or urine; they give information on bone 
formation or on bone resorption. Both types of markers are needed in a study in order to 
assess bone turnover.  
The recent meta-analysis of Darling et al. concludes that there is no clear evidence of an 
effect of protein intake on bone markers (Darling et al., 2009). Some studies reported an 
increase in bone resorption while bone formation remained stable (Kerstetter et al., 1999; 
Roughead et al., 2003; Zwart et al., 2005). However, in one of them, the authors report an 
increase of hydroxyproline (a bone resorption marker) that could be related to the protein 
source: a collagen-rich meat (Roughead et al., 2003). On the other hand, three studies 
considering both formation and resorption markers concluded that there was a positive 
effect of protein on bone. One of them observed a decrease of desoxypyridinoline (a bone 
resorption marker) with stable formation, indicating a positive decoupling (Hunt et al., 
2009). In the second study, both formation and resorption markers increased in a protein-
supplemented group compared to control during 6 months of exercise. According to the 
authors, bone formation will increase faster than bone resorption over time (Ballard et al., 
2005). In the final study, a one year soy protein supplementation only increased bone 
formation markers while resorption markers remained at the same level (Arjmandi et al., 
2005). Finally, two intervention studies reported a decrease of resorption with protein 
supplementation but provided no data on bone formation (Dawson-Hughes et al., 2004; Ince 
et al., 2004). 
3. Protein and calcium metabolism 
3.1 Urine calcium 
Urinary calcium excretion is the major pathway for body calcium loss, along with that of 
feces and sweat. A high urinary calcium level has been linked to increased bone loss 
(Giannini et al., 2003).  
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Numerous studies have reported a positive linear relationship between dietary protein and 
urinary calcium (Kerstetter & Allen, 1990; Kerstetter et al., 2003; Whiting et al., 1997). The rise 
in urinary calcium with protein intake has also been observed in more recent studies (Ceglia 
et al., 2009; Hunt et al., 2009; Jajoo et al., 2006). In one study, no effect of protein on calciuria 
was observed (Roughead et al., 2003). The mechanism underlying the effect of protein on 
calcium excretion is debated. First, a high protein diet induces an increase of glomerular 
filtration rate which will exacerbate any increased calcium excretion (Kerstetter et al., 1998). 
According to the acid ash hypothesis, the calciuric effect of a high protein intake would be 
caused by the protein-induced acid load. A meta-analysis by Fenton et al. of over 25 studies 
concluded that changes in acid excretion modulate calcium excretion (Fenton et al., 2008). 
Other studies showed that urinary calcium could be reduced by decreasing the acid load (L. 
Frassetto et al., 2005; Lemann et al., 1991). The systemic acidosis generated by the protein 
load inhibits TRPV5 calcium channel expression in the kidney. Because TRPV5 participates 
in renal calcium reabsorption, its inhibition increases urinary calcium (Nijenhuis et al., 2006).  
Another mechanism for the protein-induced calcium excretion was proposed by Conigrave 
and colleagues, involving the extracellular CaSR (Conigrave et al., 2008). CaSR found on 
cells of the parathyroid glands and in the renal tubules are sensitive not only to calcium, but 
also to some AAs (Conigrave et al., 2000). Through this double sensitivity, a link is formed 
between protein and calcium metabolism. According to these findings, AAs would activate 
the CaSRs, reducing parathormone (PTH) production and decreasing renal calcium 
reabsorption, leading eventually to an increased calcium excretion (Conigrave et al., 2008). 
Indeed, PTH level has been shown to be influenced by protein intake (Kerstetter et al., 1997, 
1998, 2006). 
Urinary calcium loss due to a high protein diet was attributed to enhanced bone resorption 
(Kerstetter & Allen, 1990); however, this view has been discussed as the link between 
protein and bone resorption is unclear (Bonjour, 2005; M. Thorpe & Evans, 2011). Urinary 
calcium excretion is mainly related to bone as the main calcium storage compartment. 
However, an increase of the excreted calcium could also be related to an increase in calcium 
absorption through the diet. Hence the effect of protein on intestinal calcium absorption 
should also be considered. 
3.2 Calcium absorption 
While many studies claim that high-protein diets cause calciuria, there is no clear 
relationship between protein intake and calcium absorption. Some studies report a positive 
effect of protein on calcium absorption (Cao et al., 2011; Hunt et al., 2009; Kerstetter et al., 
1998, 2005). One study of 13 women observed an increase in calcium absorption that 
explained 93% of the calcium excretion (Kerstetter et al., 2005). Another study reported an 
increased calciuria and a non-significant increase in calcium absorption with protein intake. 
But the net difference between calcium absorption and excretion with high or low protein 
intake remained stable (Cao et al., 2011). However, other studies observed a decrease of 
calcium absorption with protein (Dawson-Hughes & Harris, 2002; Heaney, 2000), or no 
effect at all (Roughead et al., 2003). It should be pointed out that all studies showing a 
positive effect were short term studies (2 to 7 weeks) whereas the two studies with a 
negative effect were long-term studies (years). It is thus possible that protein increases 
calcium absorption at first and that this effect is reversed in the long run. 
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The effect of protein on calcium absorption could also be conditioned by the calcium intake 
itself. Two studies tested the effect of protein intake on intestinal calcium absorption at 
different levels of calcium intake. One observed a positive effect of protein for 675 mg Ca/d 
and no effect at 1510 mg Ca/d (Hunt et al., 2009) whereas an other study observed a 
negative effect at 871 mg/d and no effect at 1346 mg/d. 
Moreover, Kerstetter et al. repeatedly showed that, in the context of low protein intake, 
there is both an increase of PTH and a decrease in calcium absorption (Kerstetter et al., 1997, 
1998, 2006). Those two findings seem incompatible because PTH is known to increase 
calcium absorption (Heaney, 2007). However, Conigrave et al., as a part of his theory on 
amino acid-sensing CaSR, proposes another mechanism not involving PTH. CaSR is also 
present in the gastro-intestinal tract, where it promotes gastric acid secretion directly and 
indirectly through gastrin release (Conigrave & Brown, 2006). High-protein diets induce the 
acidification of the intestinal content which helps calcium salts to dissolve into Ca2+, thereby 
facilitating its absorption even if PTH level is low (Conigrave et al., 2008). 
3.3 The acid-ash theory 
According to the acid-ash theory, some foods such as protein would induce a metabolic 
acidosis whereas other foods such as vegetables and fruits would counteract this process. 
The acidosis resulting from a high protein diet would be deleterious to bone and induce 
bone loss. 
Dietary proteins, and more specifically their sulphur AA content, are part of the acid-
forming nutrients. Consequently, high protein consumption would lead to metabolic 
acidosis (Frassetto et al., 1998; Kerstetter et al., 2006). pH is closely regulated in the body and 
any increase of the acid load is buffered through different pathways. The main one is 
through lung excretion of CO2, followed by kidney acid excretion. Bone has also been 
proposed to take part by releasing Ca2+ (Lemann et al., 2003). This last pathway is debated 
because the lungs’ and the kidneys’ buffering capacity are considered to be sufficient to 
compensate for the protein-induced acidosis (Bonjour, 2005). The idea that an acidic diet is 
deleterious for bone is supported by observational studies linking acid production to a 
reduced BMD (New et al., 2004; Rahbar et al., 2009; Wynn et al., 2008). Intervention studies 
on this topic usually correct the acid diet of the subjects by supplementing them with 
alkalinizing molecules. The results consistently show an improvement of bone health with 
the supplementation. This improvement occurs at the level of urinary calcium excretion 
(Frassetto et al., 2005; Lemann et al., 1991), bone turnover markers (Dawson-Hughes et al., 
2009; He et al., 2010; Maurer et al., 2003) or Bone Mineral Density (BMD) 
(Domrongkitchaiporn et al., 2002). Despite all this evidence of the beneficial effect of 
alkalinizing the diet, it should be noted that according to a recent meta-analysis, no causal 
link could be established between dietary acid load and bone disease (Fenton et al., 2011). It 
is also important to consider that the findings supporting the acid-ash hypothesis are based 
on an alkalinisation of the diet and are not directly related to protein intake. 
A decrease of pH is probably one of the main activators of bone-resorbing osteoclasts and an 
inhibitor of bone matrix deposition by osteoblasts, which explains the acid-induced bone 
reabsorption (Arnett, 2008). Extrapolation of these results to the clinical level is risky as it 
compares the in vitro pH variation to a high protein-induced acidosis. Indeed, the pH 
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variation induced by protein intake is likely to be too small to induce any effect in the bone 
micro-environment (Bonjour, 2005). 
Although they lead to different conclusions, the acid-ash theory and the hormonal anabolic 
theory are not mutually exclusive. A dual-pathway model for the effect of protein on bone 
has been proposed (M. Thorpe & Evans, 2011). Although it has been recently criticized in a 
meta-analysis (Fenton et al., 2011), it seems that there is a beneficial effect of diet 
alkalinisation. This can be achieved by lowering acidic or by increasing alkaline food 
consumption. When considering protein, the second method is more beneficial. Indeed, 
even if protein is an acid nutrient, it is also an activator of bone anabolic hormones and its 
consumption should not be lowered. This is especially true in populations already 
consuming a low protein diet such as the elderly. The acid load resulting from the protein 
consumption should be compensated by an increased consumption of alkalinizing fruits and 
vegetables.  
Some diets designed to promote weight loss rely on high protein consumption for a quick 
effect on weight. It is hard to estimate what is the effect of such diets on bone. Indeed, 
hyperproteic diets imply also potentially confounding effect such as spontaneous caloric 
restriction and a possible lack of micronutrients. Moreover, the wide variety of hyperproteic 
diets and the potential lack of compliance of the subjects further increase the difficulty of 
designing an adequate study on the subject. 
4. Protein and bone parameters 
4.1 Bone Mineral Density 
BMD is not the only determinant of skeletal fragility; the spatial distribution of the bone 
mass (as cortical and trabecular bone) and the intrinsic material properties of bone are also 
major components (Bouxsein & Seeman, 2009). Measuring BMD or Bone Mineral Content 
(BMC) is the easiest way of directly assessing bone strength in humans.  
Most observation studies report a positive association between protein and bone density 
(Hannan et al., 2000; Promislow et al., 2002) or between protein and BMD change (Dawson-
Hughes & Harris, 2002; Vatanparast et al., 2007). Specific studies showing a positive 
correlation between protein and bone density cover a broad population: premenopausal 
women (Teegarden et al., 1998), postmenopausal women (Devine et al., 2005; Ilich et al., 2003; 
Rapuri et al., 2003; M. Thorpe et al., 2008b), men (Whiting et al., 2002) and children (Alexy et 
al., 2005; Chevalley et al., 2008).  
On the other hand, two studies on premenopausal women concluded that protein intake 
had no relation with BMD (Beasley et al., 2010; Mazess & Barden, 1991). One study reported 
a negative association with BMC (Metz et al., 1993). Finally, a case-control study compared 
134 osteoporotic women with 137 controls and identified total protein intake as a risk factor 
for osteoporosis. A meta-analysis by Darling and colleagues conclude that there is no 
evidence of a negative effect of protein intake on bone when looking at observation studies; 
in fact there is probably a small positive effect of protein on bone (Darling et al., 2009).  
There are very few interventional studies comparing high vs. low protein intake. One of 
them focused on the effect of an AA and carbohydrate supplement during bed rest on 13 
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men. The study lasted 28 days and the authors reported a decrease in BMC in the 
supplemented subjects whereas BMC in control subjects remained stable (Zwart et al., 2005). 
It should be noted that energy intake was different between the two groups due to an 
energy-free placebo. Another study supplemented hospitalized elderly men and women for 
38 days with 20.4g of protein. Along with other positive effects (lower complication rate, 
shorter hospital stay), the authors reported a decrease in BMD loss with the protein 
supplement (Tkatch et al., 1992). Finally, a year-long study supplementing 62 
postmenopausal women with 25g of soy protein observed no effect on total hip BMD or 
BMC (Arjmandi et al., 2005). 
4.2 Fracture risk 
Fracture risk is the ultimate clinical outcome when considering bone. A longitudinal study 
of 32 050 postmenopausal women observed a reduced relative risk of hip fracture when 
protein intake was increased (Munger et al., 1999). Another one observed that a reduction in 
wrist fracture is positively associated with the consumption frequency of high protein food 
in 1865 perimenopausal women (D. L. Thorpe et al., 2008a). Finally, in a case-control study 
on 1167 cases of hip fractures and 1334 controls of both sexes aged 50-89, the odds ratio for 
hip fracture decreased with the increase of protein intake (Wengreen et al., 2004).  
According to these three studies, protein would have a beneficial effect on bone, but some 
other studies found conflicting results (Dargent-Molina et al., 2008; Feskanich et al., 1996; 
Meyer et al., 1997). However, it should be noted that the negative relationship between 
protein and fracture risk was significant only in the lowest quartiles of calcium intake (<400 
mg/d) and that no association was observed for higher calcium intake (Dargent-Molina et 
al., 2008; Meyer et al., 1997). Pooling four studies in a meta-analysis, Darling found no 
significant effect of protein on the risk ratio of fracture (Darling et al., 2009). To our 
knowledge, it seems that as long as calcium intake is sufficient there is a protective effect of 
protein on bone that lowers the fracture risk.  
The question of the effect of protein on fracture healing has also been addressed in some 
randomised controlled trials. All four trials were conducted by the same group and reported 
that a protein supplement improved the patients’ condition after a low-trauma femoral neck 
fracture (Delmi et al., 1990; Tkatch et al., 1992) or hip fracture (Chevalley et al., 2008; Schurch et 
al., 1998). All the clinical trials had very similar design: patients were about 80 years old and 
the protein supplement given was 20g. According to the two studies on femoral neck fracture, 
patients taking the protein supplementation had better clinical outcomes and reduced rate of 
complication and mortality during the hospital stay and 6 months after (Delmi et al., 1990; 
Tkatch et al., 1992). After hip fracture, the protein supplement increased IGF-1, attenuating 
bone loss at 6 months and shortening hospital stay (Schurch et al., 1998). The IGF-1 increase is 
independent of the type of protein given (casein, whey protein or whey protein and amino 
acids) (Chevalley et al., 2010). The beneficial effect of protein is probably linked to both the 
increased IGF-1 level and the correction of the patient nutritional state. 
5. Effect of specific protein source on bone 
Each protein bares some information in the form of its chain of amino acids. This 
information can relate to specific effects of some proteins. When protein goes through the 
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intestinal barrier, 50% are completely degraded as simple amino acids, 40% are partly 
degraded as peptides and 10% remain intact (Mallegol et al., 2005). This observation means 
that half of the digested protein reaching blood is still bearing some information in the form 
of the AA chain. Much research has tried to investigate what might be the best source of 
protein for bone health.  
5.1 Animal vs. vegetable protein 
Some observational studies considered the nature of protein source when measuring the 
effect on bone. One of them studied the relationships between the animal/vegetable protein 
ratio and bone parameters on 1035 postmenopausal women, showing that the ratio is 
positively associated with bone loss and hip fracture risk (Sellmeyer et al., 2001). However, 
the fact that a ratio was used in this study instead of the absolute values has been criticized 
(Bonjour, 2005; M. Thorpe & Evans, 2011). Other observational studies provide conflicting 
results. BMD was positively associated with animal protein intake and negatively to 
vegetable intake in one study (Promislow et al., 2002) but the opposite association was found 
when considering bone ultrasound attenuation (Weikert et al., 2005). Low levels of both 
protein types have been associated with deleterious effects on bone: low animal protein is 
related to bone loss (Hannan et al., 2000) and low vegetable protein is related to low BMD 
(Beasley et al., 2010). These results suggest that a minimum intake of both proteins is 
required regardless of the source. Finally, when considering fracture risk, a positive 
relationship was found with both animal (Dargent-Molina et al., 2008; Feskanich et al., 1996; 
Meyer et al., 1997) and vegetable protein (Munger et al., 1999; D. L. Thorpe et al., 2008a). It 
should be noted that the studies finding a positive relationship between animal protein and 
fracture risk also found a positive relationship with total protein. On the other hand, those 
finding a positive relationship between vegetable protein and fracture risk reported a 
negative one with total protein. Hence the results for animal and vegetable protein are not 
obtained in the same context.  
The intervention studies comparing animal and vegetable protein always focus on specific 
types of protein, usually soy and casein. Hence it is the specific effect of those proteins that 
is evaluated and not the one of the animal and vegetable food groups. The only whole-diet 
intervention study was based on meat or protein-rich vegetables such as nuts and grains. 
Only urinary parameters were measured and urinary calcium was similar for the two diets 
(Massey & Kynast-Gales, 2001). More studies of this type are needed to address this issue. 
Mechanistically, the reason for differentiating animal from vegetable protein is their 
differing sulphur AA content and the consequent modulation of potential acid load 
(Sellmeyer et al., 2001). The influence of sulphate content on protein efficiency has been 
emphasized in a cross-sectional study on 161 postmenopausal women. The results show a 
positive association of total protein intake with lumbar spine and total hip BMD; however, 
in lumbar spine this benefit is suppressed by the sulphur-containing AAs (M. Thorpe et al., 
2008b). The authors conclude that an excessive consumption of sulphur AAs is likely to be 
deleterious for bone. However, as underlined by Massey, the assumption that animal 
protein contains more sulphur AA than vegetable protein is not always true. As an example, 
potential acidity from sulphur AA in milk or beef is lower than that of whole wheat or white 
rice (Massey, 2003). Hence, even if sulphur AAs were proven to have a negative effect on 
bone, the extrapolation to animal and vegetable food groups is likely to give incorrect 
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results because of the broad variety of foods in these groups. In future research, it would be 
more accurate to consider an estimation of the sulphate content of each protein-containing 
food rather than focusing only on a crude animal-vegetable distinction. 
5.2 Milk proteins 
Milk contains many bioactive factors, including growth hormones, enzymes, antimicrobials, 
anti-inflammatory agents, transporters and peptide or nonpeptide hormones. Milk, because 
it contains bioactive molecules, extends beyond applications in infant nutrition and was 
considered as a possible source of factors with anabolic effects on bone.  
5.2.1 Milk Basic Proteins (MBP) 
Clinical trials showed that MBP supplementation increased BMD and decreased bone 
resorption biomarkers in healthy women (Aoe et al., 2001; Uenishi et al., 2007; Yamamura et 
al., 2002), menopausal women (Aoe et al., 2005), and healthy older women (Aoyagi et al., 
2010). In particular, MBP suppresses osteoclast-mediated bone resorption and leads to 
reduced osteoclast number in animal studies (Morita et al., 2008). Morita et al. reported that 
the protein fraction responsible for the observed activities of MBP is the bovine angiogenin 
which acts as a bone resorption-inhibitory protein (Morita et al., 2008).  
However, not all studies have shown a beneficial effect of MBP. In one study, 84 healthy 
young women were divided into three groups receiving placebo, whole milk, or milk 
containing 40 mg MBP for 8 months. Compared with the baseline values, total BMD 
significantly increased in all groups. There was a significant decrease of bone resorption 
marker N-teleopeptides of type-I collagen (NTx) while bone formation remained stable in 
both milk groups. (Zou et al., 2009).  
HPLC analysis of the major proteins in the MBP fraction identified the presence of the 
glycoprotein lactoferrin in most of these fractions (Naot et al., 2005). 
5.2.2 Lactoferrin 
Lactoferrin (LF) is an 80 kDa iron-binding glycoprotein of the transferrin family. This molecule 
has been demonstrated to inhibit in vitro osteoclast-mediated bone resorption (Lorget et al., 
2002). LF was also demonstrated to have in vitro anabolic, differentiating and anti-apoptotic 
effects on osteoblasts, and to inhibit osteoclastogenesis. Moreover in vivo local injection of LF 
above the hemicalvaria increases bone formation and bone area in adult mice (Cornish et al., 
2004). LF has a role in host non-specific defense (Gahr et al., 1991; Legrand et al., 2004). In 
addition to its direct antimicrobial effects, LF is believed to modulate the inflammatory process 
mainly by preventing the release of inflammatory cytokines which induce recruitment and 
activation of immune cells at inflammatory sites (Legrand et al., 2005). 
Investigations of our group and others established that LF at physiological concentrations 
can stimulate proliferation of primary osteoblasts and osteoblastic-cell lines and increase 
osteoblast differentiation (Blais et al., 2009; Cornish, 2004; Takayama & Mizumachi, 2008). 
Studies using 3-week culture of primary rat osteoblasts show that LF dose-dependently 
increases the number of nodules and the area of mineralized bone formed (Cornish, 2004). 
Our in vitro experiments demonstrated that LF could directly act on bone cells. Bovine LF 
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(bLF) at low physiological concentrations (5 µg/ml) stimulates growth and activity of 
osteoblastic MC3T3-E1 cells and primary culture of murine osteoblast bone cells (Blais et al., 
2009). Low density lipoprotein receptor-related protein 1 and 2, which are present on 
osteoblastic cells, have been shown to be partially responsible for LF’s mitogenic effect in 
osteoblasts (Grey et al., 2004). Moreover, Grey et al., showed that LF is able to protect 
osteoblastic cells from apoptosis induced by serum withdrawal (Grey et al., 2006).  
LF action on osteoclasts is strikingly different since it produces an important arrest of 
osteoclastogenesis (Cornish, 2004; Lorget et al., 2002). However, LF does not modulate 
mature ostoeclast activity. bLF at a concentration ranging from 10 to 1000 µg/ml was found 
to inhibit pre-osteoclastic established RAW cell growth. These results were confirmed in 
mixed primary culture of murine bone cells (Blais et al., 2009). In contrast, there was no 
effect of LF on bone resorption when tested on isolated mature osteoclasts, or in organ 
cultures that can detect mature osteoclast activity (Grey et al., 2006).  
In vivo bone effects of LF were first studied using local injection of LF above the 
hemicalvaria which increased bone formation and bone area in adult mice (Cornish, 2004). 
Few recent studies using ovariectomized (OVX) rodents as a model for post menopausal 
bone loss measured the effect of dietary supplementation on bone (Blais et al., 2009; Guo et 
al., 2009; Malet et al., 2011). LF administered orally to OVX rats for three months protected 
them against the OVX-induced reduction of bone volume and BMD and increased the 
parameters of mechanical strength, increased bone formation and reduced bone resorption 
(Guo et al., 2009). Our studies using OVX mice demonstrated that the dietary bLF transfer 
into peripheral blood. LF supplementation increases BMD and bone strength compared to 
the OVX control group. This study supports a direct effect of LF on bone cells (Blais et al., 
2009).  
Recent animal studies demonstrated that estrogen deficiency causes bone loss by 
mechanisms associated with inflammatory and oxidative processes (Grassi et al., 2007; Lean 
et al., 2003; Muthusami et al., 2005). TNFis one of the cytokines responsible for the 
augmented osteoclastogenesis (Suda et al., 1999). Indeed, ovariectomy causes an increase in 
TNF production from T-cells which in turn increases macrophage colony-stimulating factor 
and RANKL levels, leading to osteoclastogenesis (Cornish et al., 2004; Suda et al., 1999). 
Moreover the presence of increased levels of TNFwas reported in the bone marrow of OVX 
animals and in blood cells of postmenopausal women (Oh et al., 2007; Shanker et al., 1994). 
Postmenopausal osteoporosis should also be regarded as the result of an inflammatory process 
(Weitzmann & Pacifici, 2007). It has been shown that bLF plays a role in host non-specific 
defense and modulates the inflammatory process mainly by preventing the release of 
inflammatory cytokines that induce recruitment and activation of immune cells at 
inflammatory sites (Debbabi et al., 1998; Legrand et al., 2006). Indeed, bLF enriched diet 
ingestion can reduce release of pro-inflammatory cytokines and increase anti-inflammatory 
cytokine production. Our studies showed that bLF ingestion decreases bone loss and bone 
resorption markers. A decreased TNFmRNA expression associated with a TNFproduction 
inhibition on peripheral T-lymphocytes was observed with a bLF supplementation in OVX 
mice. Furthermore, bLF can prevent lymphocyte activation and cytokine release in the bone 
micro-environment. Production and release of TNFwere strongly down-regulated by LF. 
These immune modulations were spatially and temporally correlated with reduced bone 
loss. We suggested that bLF modulates the inflammatory process via specific TNF 
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inhibition in order to improve bone loss (Malet et al., 2011). Recently a clinical trial of 38 
healthy postmenopausal women randomized into placebo or ribonuclease-enriched-LF (R-
ELF) groups evaluated bone health status over a period of 12 months. The authors 
demonstrated that R-ELF supplementation reduced bone resorption and increased 
osteoblastic bone formation; however BMD was not evaluated (Bharadwaj et al., 2009). 
In conclusion, LF has a positive effect on bone health and might be useful in pathological 
states of reduced bone density. The molecular mechanisms are not fully understood but our 
studies suggest that dietary bLF supplementation can have a beneficial effect on 
postmenopausal bone loss not only via a direct effect but also by modulating immune 
function. The development of pharmaceutical or nutriceutical compounds that are based on 
LF will require a better understanding of LF’s mechanism of action on bone. 
5.3 Collagen 
Collagen has a unique triple helix configuration with a repeating sequence (Gly-X-Y)n, with 
X and Y being mostly proline and hydroxyproline (Hyp) (Bos et al., 1999; Ramshaw et al., 
1998). Some studies suggest that a hydrolyzed collagen-enriched diet improves bone 
collagen metabolism and BMD. Oral administration of Hydrolyzed Collagen (HC) increased 
BMC and BMD in rats and mice fed a calcium or protein deficient diet (Koyama et al., 2001; 
Wu et al., 2004). 
5.3.1 Ingestion of collagen 
Oral administration of HC was demonstrated to increase the quantity of type I collagen and 
proteoglycans in the bone matrix of ovariectomized rats (Nomura et al., 2005). Moreover, in 
patients with osteoporosis, oral intake of HC with calcitonin had a stronger inhibitory effect 
on bone resorption than calcitonin alone (Adam et al., 1996). Oesser et al. demonstrated the 
intestinal absorption and cartilage accumulation of collagen-derived peptides (Oesser et al., 
1999). It has been generally assumed that collagen–rich diets interact with the bone matrix. 
Indeed, collagen-derived di- and tripeptides rich in hydroxyproline such as Hyp, Pro-Hyp, 
Pro-Hyp-Gly or Gly-Pro-Val have been detected in human blood following the ingestion of 
HC (Iwai et al., 2005). The PEPT1 proton-dependent transporter assures the transport of Pro-
Hyp across the intestinal barrier (Aito-Inoue et al., 2007). 
A study of Ohara et al. compared quantity and structures of food-derived gelatin 
hydrolysates in human blood from fish scale, fish skin and pork skin type I collagen in a 
single blind crossover study (Ohara et al., 2007). Amounts of free Hyp and Hyp-containing 
peptide were measured over a 24-h period. Hyp-containing peptides comprised 
approximately 30% of all detected Hyp. However, efficiency of HC ingestion depends not 
only on collagen origin but also on the molecular size of the HC. Collagen needs to be 
hydrolysed to be able to interact with bone metabolism. 
5.3.2 In vivo studies 
Our in vivo studies indicate that ingestion of HC diet induced the growth of the external 
diameter of the bone cortical zone in OVX mice (Guillerminet et al., 2010, 2011). The 
increased cortical area was correlated with a significant increase in the femur external 
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diameter, without modification of the size of the medullar area. Therefore, the increased size 
of the cortical area was induced by a periosteal apposition of bone on the mouse femur. Due 
to this increase in bone size, the ultimate strength of femurs of OVX-mice ingesting HC was 
significantly greater than the control OVX mice. The increase of the external diameter was 
also related to a higher level of bone ALP during the first month of HC ingestion. However, 
the effect was transient; after three months no significant ALP increase was reported. 
Moreover, HC ingestion was able to increase the bone non-mineral content. There was no 
significant modification of Young’s modulus but bone stiffness increased. Assuming that the 
stiffness of bone is correlated to the amount of type I collagen present (Burr, 2002; Mann et 
al., 2001), and since some previous studies showed an increase of type I collagen and 
proteoglycan excretion for mice fed hydrolyzed collagen, we can propose that HC ingestion 
increases type I collagen formation in mouse bone.  
5.3.3 In vitro studies 
The in vitro results obtained with primary tissue culture of murine bone cells confirmed that 
HC was able to stimulate cell growth and ALP activity. In our studies, all the tested 
collagens were able to increase osteoblast activity but the 2kDA porcine HC was the most 
efficient in vitro (Guillerminet et al., 2010). Similar observations were also reported with 
osteoblasts grown on collagen type I films compared to a plastic support with an 
improvement in various bone markers including increased ALP activity and an accelerated 
and uniform mineralization of the bone matrix (Lynch et al., 1995). Moreover, our work 
using the in vitro BD BioCoatTM OsteologicTM bone cell culture system showed that PCH-N 
hydrolyzed collagen did not modify osteoclast growth but reduced osteoclast differentiation 
(Guillerminet et al., 2010). This effect, combined with increased osteoblast activity is likely to 
modulate bone turnover leading to the growth of the external diameter of cortical bone.  
5.3.4 Mechanism of action 
Several potential mechanisms can be proposed to explain the influence of HC-derived 
peptides on bone metabolism. Some results have suggested that ingestion of type I 
hydrolyzed collagen leads to the production and absorption of collagen-derived peptides 
similar to peptides released from type I collagen in situ during bone resorption. Those 
peptides also act on bone cell metabolism (Adam et al., 1996). Osteoblast activity involves 
three steps including proliferation, matrix protein synthesis (type I collagen and 
proteoglycans) and mineralization of the bone matrix (Owen et al., 1991; Quarles et al., 1992; 
Stein & Lian, 1993). Several hormones and cytokines can modulate osteoblast and osteoclast 
differentiation and activity. The cytokine TGF-┚ which is stored in a latent form in the bone 
matrix, and secreted during the bone resorption phase, is believed to exert such an effect 
(Oreffo et al., 1989). TGF-┚ stimulates type I collagen and proteoglycan production while 
inhibiting that of hydroxyapatite. Interestingly, the type I collagen-derived peptide DGEA 
(asparagine, glycine, glutamine and alanine), was shown to interact with ┙2┚1 integrin 
located on the osteoblast cell membrane. This interaction leads to inhibition of TGF-┚ and 
consequently bone matrix protein synthesis (Oesser et al., 1999; Takeuchi et al., 1996, 1997; 
Xiao et al., 1998). Moreover, Hyp is an aromatic AA, and an increase of its concentration can, 
as suggested previously, increase IGF-1 levels which consequently attenuates bone loss.  
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Taken together, the results indicate that hydrolyzed collagen modulates bone formation and 
mineralization of the bone matrix by stimulating osteoblast growth and differentiation while 
reducing osteoclast differentiation. These effects lead to growth of the external diameter of 
the cortical zone.  
5.4 Isoflavone-containing soy protein 
Soy contains isoflavones able to bind to estrogen receptors (Folman & Pope, 1969). They 
have received considerable interest as a possible alternative to conventional Hormone 
Replacement Therapy (HRT). However, the efficiency of phytoestrogens such as soy 
isoflavone on bone is still to be proven. 
Epidemiological studies suggest that populations with high soy intake (such as Asian 
populations) have a lower incidence of osteoporotic fractures (Adlercreutz & Mazur, 1997; 
Schwartz et al., 1999). Asian women typically consume about 20g of soy daily which 
provides 40 mg of isoflavones (Chen et al., 1999; Ho et al., 2003). However, lower rates of 
fracture in these populations may not be fully attributed to soy consumption as ethnic 
related variation in fracture rates can also be explained by differences in bone structure 
(Bouxsein, 2011).  
Many animal studies show that soy protein and/or its isoflavones have positive effects on 
bone mineral density (BMD) (Arjmandi et al., 1998a, 1998b). However, clinical trial results 
ranged from no significant changes (Alekel et al., 2000; Dalais et al., 1998; Gallagher et al., 
2004; Kreijkamp-Kaspers et al., 2004; Potter et al., 1998) to a slight increase (Chiechi et al., 
2002; Lydeking-Olsen et al., 2004; Potter et al., 1998) in BMD. The bone protective effects of 
soy and/or its isoflavones are at best inconclusive. 
5.4.1 Types of isoflavones 
The major isoflavones in soy foods include genistein and diadzein. Genistein 2 has one-third 
of the potency of estradiol 1 when it interacts with estrogen receptor-b (ER-b), and one-
thousandth of the potency of estradiol 1 when it interacts with ER-a. Hence Genistein 2 can 
induce a small estradiol-like response in bone tissues (Adlercreutz & Mazur, 1997; Zhou et 
al., 2003). Another isoflavone, called equol, is not present in soybean but is a metabolic 
product of the biotransformation of diadzein by gut bacteria (Setchell et al., 2002). 80% of the 
Asian population are equol producers (Fujimoto et al., 2008; Morton et al., 2002). In contrast, 
as few as 25% of individuals in North America and Europe are able to make S-equol (Lampe 
et al., 1998).  
5.4.2 Isoflavone and bone fracture 
A number of reviews describe the effects of dietary soy and isoflavones on bone (Jackson et 
al., 2011; Messina, 2010; Reinwald & Weaver, 2010). Among the studies exploring the effect 
of isoflavone-containing food on BMD in postmenopausal women, few report a relationship 
between soy consumption and the risk of bone fracture. A clinical trial conducted by Marini 
et al. found that in postmenopausal osteopenic Italians receiving 54mg/day genistein for 
two years, spinal BMD increased by 5.8% (n=150), whereas it decreased in the placebo group 
by 6.3% (n=154). Similar effects were reported for the hip (Marini et al., 2007). However, 
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recently published long-term trials do not confirm these results; only the trial conducted by 
Alekel et al. reports a modest effect at the femoral neck with 120mg/d isoflavone but no 
effect with 80mg/d (Alekel et al., 2009).  
In contrast clinical trials investigating associations between soy-food intake and BMD in 
Japanese or Chinese healthy postmenopausal women report that higher isoflavone 
consumption is associated with lower risk of bone fracture (Ho et al., 2003; Ikeda et al., 2006; 
Kaneki et al., 2001). Analysis of fracture incidence in the Shanghai cohort (Zhang et al., 2005) 
and of hip fracture in the Singapore cohort (Koh et al., 2009) shows in both studies one-third 
reductions in fracture risk when comparing high- with low-soy consumers.  
5.4.3 Factors modulating the effect of soy on bone health 
The effectiveness of dietary adaptation of western populations which rarely consumed soy 
must be considered. East Asian participants in epidemiological studies did not require an 
adaptation period or an interruption of life-long dietary habits like a western population 
would. Hence the observation cannot be extrapolated from one population to another.  
It may be less difficult to determine bone effects following a life-long intake of traditional 
foods compared with intermittent intakes of soy. Traditional soy foods are a complex blend 
of isoflavones, protein, lipids, vitamins, minerals and other bioactive compounds that may 
act individually and/or synergistically to exert healthy effects. Supplements included in 
western diets provide quantities of individual soy components. Types of whole soy food 
consumed (fermented vs. nonfermented) and/or ethnicity (equol producers) may also affect 
outcome interpretation of soy bone effects. 
Long-term observational studies in Asian populations support a benefit of traditional soy 
food consumption on bone health in this population. The health effects of soy-bean 
phytoestrogens in non-Asian postmenopausal women are promising. No conclusive 
evidence supports that the isoflavones from the sources studied do have beneficial effects on 
bone health. More researches are needed to clarify the role of dietary phytoestrogen in 
osteoporosis prevention.  
6. Conclusion 
Protein acts on bone metabolism at different levels and through different mechanisms. 
There is little evidence that a high-protein diet will increase bone loss. Protein is well-known 
to be calciuric, yet there are conflicting data on whether the excreted calcium comes from an 
increase of calcium absorption or from bone resorption. The direct effects of protein on bone 
turnover markers and BMD seem to be positive when considering observational studies, but 
interventional studies do not provide significant outcomes to conclude. Finally, when 
considering fracture rate, there seems to be a small positive effect of protein on bone as long 
as calcium levels remain adequate. 
Two mechanisms are proposed to explain the action of protein on bone: the acid-ash theory 
and the hormonal anabolic effect through IGF-1 and CaSR. The hormonal anabolic 
mechanism supports the fact that protein is beneficial to bone by increasing IGF-1. On the 
other hand, the acid-ash theory considers that the acid load due to protein consumption is 
harmful to bone. If both mechanisms occur at the same time, it is possible to benefit from the 
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protein-induced IGF-1 without the negative effect of the acid load by compensating the diet 
with adequate alkalinizing foods. 
Dietary protein quality adds complexity to the protein debate. It has been hypothesized that 
animal protein would be more deleterious to bone than vegetal protein. However, studies 
show no real difference between those two protein sources. Similarly, long-term 
observational studies support a benefit of traditional soy food consumption on bone health, 
but no conclusive evidence supports the hypothesis that this is due to the isoflavones. On 
the other hand, some peptides obtained from protein digestion have been shown to be 
helpful to prevent bone loss. Recent results indicate that HC could be of potential interest 
for nutritional intervention in the prevention of bone loss. Moreover, LF has been reported 
to have a positive effect on bone health and might be useful in pathological states of reduced 
bone density. The molecular mechanisms are not fully understood but our studies suggest 
that dietary bLF supplementation can have a beneficial effect on postmenopausal bone loss 
not only by acting on bone cells but also by modulating immune function. 
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